Health-related quality of life (HRQoL) outcomes from the randomized, double-blind phase 3 KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC)

Título:	Health-related quality of life (HRQoL) outcomes from the randomized, double-blind phase 3 KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC)
Autores/as:	Garassino, Marina Chiara Wakelee, Heather A. Spicer, Jonathan Liberman, Moishe Kato, Terufumi Tsuboi, Masahiro Lee, Se-Hoon Chen, Ke-Neng Dooms, Christophe Alfons Majem, Margarita Eigendorff, Ekkehard Martinengo, Gaston L. Bylicki, Olivier Rodríguez Abreu, Delvys Chaft, Jamie E. Yang, Jing Arunachalam, Ashwini Norquist, Josephine M. Keller, Steven M. Gao, Shugeng
Clasificación UNESCO:	32 Ciencias médicas 320713 Oncología 3209 Farmacología
Fecha de publicación:	2024
Publicación seriada:	Journal of Clinical Oncology
Conferencia:	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
URI:	https://accedacris.ulpgc.es/handle/10553/132803
ISSN:	0732-183X
Fuente:	Journal Of Clinical Oncology[ISSN 0732-183X],v. 42 (16) sup. S, Abstract 8012, (Junio 2024)
Colección:	Actas de congresos

Vista completa